Parisian stent developer nets $22M in series B financing

Justine Varieur Cadet | | Cardiovascular Business | Interventional Cardiology
Coronary stent developer Stentys has secured the second tranche of its Series B financing from Sofinnova Partners and Scottish Equity Partners -- closing an additional $4.2 million investment from new investor Crédit Agricole Private Equity -- bringing the total B round financing to more than $22 million.

The Paris-based Stentys was founded in 2006 to develop a new stent designed for treatment of acute MI and coronary artery bifurcations.

"Stentys has completed an initial 40 patient clinical trial demonstrating safety and efficacy of the stent," said Gonzague Issenmann, Stentys' CEO. "This second financing tranche of the Series B round will enable Stentys to obtain CE marking and begin European marketing of the first self-expanding stent platform for the treatment of MI."

Justine Varieur Cadet

Related Content

Cardiologists reflect on developing primary PCI in face of criticism and pushback
How TAVR valve choice impacts outcomes when treating type 1 bicuspid AS
IVUS-guided PCI reduces risks in patients with diabetes
Medtronic using AI to identify more TAVR patients in need
SAVR linked to higher 10-year survival rate than TAVR for low-risk patients
LAAC with Watchman FLX reduces bleeding risks after AFib ablation

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."